Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic effects of β-D-mannuronic acid in patients with ankylosing spondylitis
IRCT2013062213739N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of D-mannuronic acid in ankylosing spondylitis (AS), sponsored by Tehran University of Medical Sciences. Started Apr 2014; status: completed.
02
Drugs
D-mannuronic acid
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on IRCT2013062213739N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013062213739N1.